Rayonier Adv Materials 株価情報 (NYSE: RYAM)

Rayonier Adv Materials (NYSE:RYAM) 株価情報

Rayonier Adv Materials

Rayonier Advanced Materials Inc manufactures high-purity cellulose derived from wood. Also known as cellulose specialties, the company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, High-Yield Pulp, and Corporate and Other. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of revenue from the United States.

Rayonier Advanced Materials Inc. Common Stock

Rayonier Advanced Materials Inc

Rayonier Advanced Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) announced its preliminary financial results for the fiscal <a target="_blank" href="https://www.benzinga.com//node/43451249" rel="noreferrer noopener">year ended December 31, 2024.</a>
Net sales for 2024 were $1.639 billion, down slightly by $4 million from the previous year. The analyst consensus estimate pegs at $1.626 billion.
Looking ahead, Rayonier expects a moderate increase in average sales prices for its Cellulose Specialties products in 2025, although sales volumes are anticipated to decline due to the suspension of its Temiscaming High Purity Cellulose plant.
The company is also actively assessing the potential impact of a 25% tariff on Canadian paperboard exports to the U.S., which could cost up to $3.5 million per month.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43450261/trump-trudeau-strike-border-security-deal-tariffs-on-canada-paused-for-at-least-30-days" rel="noreferrer noopener">Trump, Trudeau Strike Border Security Deal, Tariffs On Canada Paused For &#8216;At Least 30 Days &#8216;</a>
The company reported a loss from continuing operations for 2024&nbsp;of $43 million, though this was an improvement of $59 million compared to 2023. Adjusted EBITDA saw a significant increase, rising 60% to $222 million, reflecting operational enhancements and a favorable market environment in the Cellulose Specialties business, especially at the end of the year. Adjusted EBITDA margin also improved, reaching 13.5% from 8.5% in 2023.
Cash flow also showed strong performance, with cash provided by operating activities increasing by $69 million to $205 million. Adjusted free cash flow rose to $130 million, a gain of $77 million year-over-year.
Rayonier&#8217;s net secured leverage stood at 2.7x, well below its covenant of 5.0x.
Despite this, Rayonier remains confident in its ability to cover all fixed charges, including maintenance capital and interest expenses.
Price Action: RYAM shares closed lower by 3.75% to $7.70 on Monday.
Read Next.
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43447339/trump-announces-us-sovereign-wealth-fund-hints-at-tiktok-ownership" target="_blank" rel="noreferrer noopener">Trump Orders US Sovereign Wealth Fund, Hints At TikTok Ownership: ‘I Have The Right To Do That'</a></li>
</ul>
Photo: Visuals6x via Shutterstock.

Equities

News

Guidance

Markets

Movers

General

RYAM

Tariff Trouble: Rayonier Advanced Materials Braces For $3.5M Monthly Loss Due To New 25% Paperboard Tax

In 2024, approximately 11% of RYAM's total revenues were generated from Canadian Paperboard exports to the U.S. The Company has been proactively pursuing mitigation actions since late 2024 to partially offset these impacts. If the proposed 25% tariff on Canadian shipments to the U.S. is enacted, the Company would expect an impact of up to $3.5 million per month while in place.
Also, 2025 Cellulose Specialties average sales prices are projected to increase mid-single-digit percentage from 2024 levels, in line with RYAM's "value over volume" strategy. 2025 Cellulose Specialties sales volumes are expected to decline versus 2024 levels due to the indefinite suspension of the Temiscaming High Purity Cellulose plant; however, 2025 revenue is expected to be flat to 2024 levels.

Rayonier Advanced Materials Says Actively Assessing Impact Of Tariffs; If The Proposed 25% Tariff On Canadian Shipments To US Is Enacted, Company Would Expect Impact Of Up To $3.5M Per Month

Rayonier Advanced Materials Reports Preliminary 2024 Net Sales Of $1.639B (Est $1.626B), A Decline Of $4M From Prior Year

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 100 points on Tuesday.
Shares of Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) fell sharply in today's pre-market trading following <a href="https://www.benzinga.com/quote/PII/earnings">fourth-quarter results</a>.
Polaris reported quarterly adjusted earnings of 92 cents per share which beat the analyst consensus estimate of 89 cents per share The company reported quarterly sales of $1.75 billion which beat the analyst consensus estimate of $1.69 billion.
Polaris said it sees FY25 sales of (-1)% to (-4)%.
Polaris shares tumbled 7.1% to $52.49 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Juniper Networks, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>) shares dipped 10.1% to $34.75 in pre-market trading. Liberty Global and Juniper Networks collaborated to demonstrate seamless cloud connections.</li>
<li>Greenfire Resources Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFR#NASDAQ">GFR</a>) dipped 6.2% to $6.21 in pre-market trading.</li>
<li>Radiant Logistics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLGT#NYSE">RLGT</a>) shares fell 5.5% to $6.71 in pre-market trading.</li>
<li>Stagwell Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STGW#NASDAQ">STGW</a>) fell 5% to $6.30 in pre-market trading.</li>
<li>Rayonier Advanced Materials Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) declined 3.1% to $7.71 in today's pre-market trading.</li>
<li>Kodiak Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOD#NASDAQ">KOD</a>) dipped 3.1% to $7.31 in pre-market trading after falling over 5% on Monday.</li>
<li>General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) fell 2.6% to $53.50 in pre-market trading following fourth-quarter earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43230206/jim-cramer-is-worried-about-this-consumer-cyclical-stock-7-yield-something-may-be-wrong-here">Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? &#8216;Something May Be Wrong Here&#8217;</a></li>
</ul>

Pre-Market Outlook

Trading Ideas

JNPR

RLGT

STGW

Polaris, General Motors And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Tuesday.
Shares of New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) fell sharply in today's pre-market trading after the company announced <a href="https://www.benzinga.com/quote/EDU/earnings">weak quarterly earnings</a>.
The company reported quarterly adjusted earnings of 22 cents per share which missed the analyst consensus estimate of 30 cents per share. The company reported quarterly sales of $1.04 billion which beat the analyst consensus estimate of $1.03 billion.
New Oriental Education &amp; Technology Group shares dipped 16.2% to $50.98 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>TechTarget, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) shares tumbled 19.5% to $14.00 in pre-market trading.</li>
<li>Baird Medical Investment Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) fell 18.2% to $7.24 in today's pre-market trading after jumping 63% on Friday.</li>
<li>Ranpak Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NYSE">PACK</a>) shares dipped 18.2% to $5.21 in pre-market trading.</li>
<li>Rayonier Advanced Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) declined 17.1% to $6.24 in pre-market trading</li>
<li>SWK Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) dipped 14.3% to $14.00 in pre-market trading.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) fell 6.8% to $11.66 in pre-market trading following a report suggesting that the U.S. Justice Department filed a lawsuit against the company.</li>
<li>Contineum Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNM#NASDAQ">CTNM</a>) fell 6.8% to $11.60 in pre-market trading.</li>
<li>Tile Shop Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTSH#NASDAQ">TTSH</a>) fell 3.6% to $6.78 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43091705/top-4-health-care-stocks-you-may-want-to-dump-in-q1">Top 4 Health Care Stocks You May Want To Dump In Q1</a></li>
</ul>

BDMD

CTNM

New Oriental Education & Technology Group

PACK

SWKH

TTGT

TTSH

New Oriental Education, Walgreens And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Shares of INNOVATE Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) rose sharply in today's <a href="https://www.benzinga.com/quote/VATE">pre-market trading</a>.
INNOVATE announced the FDA approval of MediBeacon&#8217;s TGFR System For accurate kidney function testing.
INNOVATE shares jumped 19.4% to $6.10 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>EON Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EONR#NYSE">EONR</a>) gained 89.2% to $1.93 in pre-market trading.</li>
<li>Dogwood Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) rose 62.5% to $3.04 in pre-market trading after falling 3% on Friday.</li>
<li>Crown Electrokinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) rose 43.5% to $0.1794 in pre-market trading. Crown Electrokinetics shares jumped around 57% on Friday after the company announced it entered into an exclusive partnership with Electro Scan.</li>
<li>Trio Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NYSE">TPET</a>) gained 30.7% to $2.33 in pre-market trading. Trio Petroleum said as of Jan. 7, it has fully repaid senior secured convertible promissory notes with aggregate principal of $1.6 million.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) gained 22.9% to $43.21 in pre-market trading.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) gained 22.8% to $0.9185 in pre-market trading.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) gained 22.6% to $1.63 in pre-market trading.</li>
<li>First Foundation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFWM#NYSE">FFWM</a>) gained 12.7% to $7.09 in pre-market trading. First Foundation will release its fourth quarter 2024 earnings results before the opening bell on Thursday, Jan. 30.</li>
<li>Riskified Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) gained 9.2% to $5.49 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Canoo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) fell 72.3% to $0.3736 in pre-market trading after the company announced Chapter 7 bankruptcy filing, ending operations effective immediately.</li>
<li>Orangekloud Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) shares fell 30.3% to $0.78 in pre-market trading after dipping 72% on Friday.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) fell 29.4% to $6.14 in pre-market trading after gaining over 5% on Friday.</li>
<li>IF Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) shares dipped 29.4% to $18.00 in pre-market trading after gaining 6% on Friday.</li>
<li>TechTarget, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) shares tumbled 19.5% to $14.00 in pre-market trading.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares fell 19.4% to $5.10 in pre-market trading.</li>
<li>Baird Medical Investment Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) fell 18.2% to $7.24 in today's pre-market trading after jumping 63% on Friday.</li>
<li>Rayonier Advanced Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) declined 17.1% to $6.24 in pre-market trading</li>
<li>New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) fell 16.2% to $50.98 in pre-market trading after the company announced weak quarterly earnings.</li>
<li>SWK Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) dipped 14.3% to $14.00 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43089042/3m-netflix-and-3-stocks-to-watch-heading-into-tuesday">3M, Netflix And 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>

ATPC

CGBS

CRKN

DWTX

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

TMCI

TPET

VATE

Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket

Financing

Ryonier Advanced Material Raises €67M In Green Capital To Invest In Biomaterials Strategy

RBC Capital analyst Matthew McKellar maintains Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) with a Outperform and raises the price target from $10 to $12.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on Rayonier Adv Materials, Raises Price Target to $12

U.S. stocks were higher, with the Dow Jones index gaining around 1,300 points on Wednesday.
Shares of Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) rose sharply during Wednesday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/MRCY/earnings">quarterly financial results.</a>
Mercury Systems reported quarterly earnings of 4 cents per share which beat the analyst consensus estimate of a loss of 8 cents per share. The company reported quarterly sales of $204.431 million which beat the analyst consensus estimate of $181.772 million.
Mercury Systems shares jumped 16.7% to $39.90 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>The GEO Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) shares jumped 36.2% to $20.60.</li>
<li>CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) shares gained 28.2% to $17.47.</li>
<li>Cytek Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTKB#NASDAQ">CTKB</a>) jumped 28% to $6.96 following upbeat quarterly results.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) shares gained 26.3% to $7.22 following strong quarterly results.</li>
<li>United Fire Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFCS#NASDAQ">UFCS</a>) surged 23.3% to $24.58 following upbeat quarterly earnings.</li>
<li>Revolve Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) gained 19.8% to $31.18 following third-quarter results.</li>
<li>Rayonier Advanced Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) rose 19.8% to $9.75 after posting third-quarter results.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) gained 18.3% to $229.39.</li>
<li>ArcBest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) rose 16.6% to $121.35 following quarterly results.</li>
<li>Kennametal Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) gained 16.3% to $30.91 following better-than-expected quarterly earnings.</li>
<li>Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) gained 16.2% to $66.03.</li>
<li>Evercore Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) rose 15.4% to $313.80.</li>
<li>Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) surged 15.2% to $166.57.</li>
<li>Piper Sandler Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NASDAQ">PIPR</a>) rose 15.1% to $334.57.</li>
<li>Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) surged 14.9% to $28.68.</li>
<li>Qualys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) gained 13.6% to $145.65 after the company reported better-than-expected third-quarter financial results and raised its FY24 guidance.</li>
<li>Capital One Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) gained 12.8% to $187.38.</li>
<li>Steel Dynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) surged 12.8% to $153.07.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose 12.6% to $282.93 following Trump win.</li>
<li>The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) gained 12.4% to $592.23.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) surged 10.7% to $61.26 following strong quarterly revenue.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too Hig</a><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">h</a>&#8216;</li>
</ul>

Intraday Update

ARCB

COIN

CTKB

HOOD

MRCY

PIPR

QLYS

RVLV

STLD

TSLA

UFCS

Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday

WIIM

Rayonier Advanced Materials shares are trading higher. The company reported Q3 financial results.

Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.08) by 50 percent. This is a 70 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $401.00 million which missed the analyst consensus estimate of $410.10 million by 2.22 percent. This is a 8.67 percent increase over sales of $369.00 million the same period last year.

Earnings

Earnings Misses

Rayonier Adv Materials Q3 Adj $(0.12) Misses $(0.08) Estimate, Sales $401.00M Miss $410.10M Estimate

Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) .

Rayonier Adv Materials expects FY2024 Adj. EBITDA of $205M-$215M, Adj. Free Cash Flow of $115M-$125M.

Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) will release its quarterly earnings report on Tuesday, 2024-11-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Rayonier Adv Materials to report an earnings per share (EPS) of $-0.11.
Anticipation surrounds Rayonier Adv Materials's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.29, leading to a 30.12% increase in the share price the following trading session.
Here's a look at Rayonier Adv Materials's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.10</td>
<td>-0.10</td>
<td>-0.07</td>
<td>-0.24</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.19</td>
<td>-0.02</td>
<td>-0.22</td>
<td>-0.40</td>
</tr>
<tr>
<td>Price Change %</td>
<td>30.0%</td>
<td>2.0%</td>
<td>-21.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730750472_0.png" alt="eps graph" />
<h3>Market Performance of Rayonier Adv Materials's Stock</h3>
Shares of Rayonier Adv Materials were trading at $8.1 as of November 01. Over the last 52-week period, shares are up 167.21%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Views on Rayonier Adv Materials</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Rayonier Adv Materials.
Analysts have provided Rayonier Adv Materials with 2 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $9.5, suggesting a potential 17.28% upside.
<h3>Comparing Ratings with Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Ginkgo Bioworks Holdings, Ecovyst and Alto Ingredients, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>As per analysts' assessments, Ginkgo Bioworks Holdings is favoring an Buy trajectory, with an average 1-year price target of $8.5, suggesting a potential 4.94% upside.</li>
<li>As per analysts' assessments, Ecovyst is favoring an Buy trajectory, with an average 1-year price target of $10.5, suggesting a potential 29.63% upside.</li>
<li>Analysts currently favor an Buy trajectory for Alto Ingredients, with an average 1-year price target of $5.5, suggesting a potential 32.1% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary provides a snapshot of key metrics for Ginkgo Bioworks Holdings, Ecovyst and Alto Ingredients, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>8.73%</td>
<td>$48.31M</td>
<td>1.52%</td>
</tr>
<tr>
<td>Ginkgo Bioworks Holdings</td>
<td>Buy</td>
<td>-30.24%</td>
<td>$42.48M</td>
<td>-23.88%</td>
</tr>
<tr>
<td>Ecovyst</td>
<td>Buy</td>
<td>-1.98%</td>
<td>$53.66M</td>
<td>1.98%</td>
</tr>
<tr>
<td>Alto Ingredients</td>
<td>Buy</td>
<td>-25.47%</td>
<td>$7.55M</td>
<td>-1.28%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Rayonier Adv Materials ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, it is also in the middle.
<h3>Discovering Rayonier Adv Materials: A Closer Look</h3>
Rayonier Advanced Materials Inc manufactures high-purity cellulose derived from wood. Also known as cellulose specialties, the company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, High-Yield Pulp, and Corporate and Other. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of revenue from the United States.
<h3>Rayonier Adv Materials: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Rayonier Adv Materials displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 8.73%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Rayonier Adv Materials's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 2.72%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Rayonier Adv Materials's ROE stands out, surpassing industry averages. With an impressive ROE of 1.52%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Rayonier Adv Materials's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.53%, the company showcases efficient use of assets and strong financial health.
Debt Management: Rayonier Adv Materials's debt-to-equity ratio stands notably higher than the industry average, reaching 1.03. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<a href="https://www.benzinga.com/quote/RYAM/earnings">To track all earnings releases for Rayonier Adv Materials visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What's Next: Rayonier Adv Materials's Earnings Preview

RYAM Raises $700M In Aggregate Principal Amount Of Secured Term Loan Financing From Funds Managed By Capital Management

Rayonier Advanced Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) ("RYAM"), a leader in High Purity Cellulose, today announced that its Jesup, Georgia facility has fully resumed operations ahead of schedule, following an isolated fire on October 11. All production lines have returned to producing on-grade material at full capacity.

RYAM's Jesup Facility Resumes Full Production Ahead Of Schedule, Following An Isolated Fire On October 11

Rayonier Advanced Materials shares are trading lower after the company provided an update on a fire at its plant in Jesup, Georgia.

Rayonier Advanced Materials Joint Venture, Altamaha Green Energy, Receives Certified Purchase Power Agreement ToProduce And Sell Up To 70 MW Of Electricity To Georgia Power Company

RBC Capital analyst Matthew McKellar maintains Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) with a Outperform and raises the price target from $9 to $10.

RBC Capital Maintains Outperform on Rayonier Adv Materials, Raises Price Target to $10

Rayonier Advanced Materials Increases Cellulose Specialties Product Prices By 10%

RBC Capital analyst Matthew McKellar maintains Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) with a Outperform and raises the price target from $7 to $9.

RBC Capital Maintains Outperform on Rayonier Adv Materials, Raises Price Target to $9

Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Rayonier Advanced Materials Inc. - RYAM

Press Releases

RYAM Announces Strong Preliminary 2024 Financial Results and Provides Update on Tariffs

Comments

Rayonier Adv Materials

ニュース

パートナーシップ

ベンジンガ・グローバル